CBR-470-1 protects against cardiomyocyte death in ischaemia/reperfusion injury by activating the Nrf2-GPX4 cascade.

MLA

Qiu, Ze-Yang, et al. “CBR-470-1 Protects against Cardiomyocyte Death in Ischaemia/Reperfusion Injury by Activating the Nrf2-GPX4 Cascade.” Toxicology and Applied Pharmacology, vol. 492, Nov. 2024, p. 117113. EBSCOhost, https://doi.org/10.1016/j.taap.2024.117113.

APA

Qiu, Z.-Y., Shi, K.-N., Li, H.-H., & Zhang, B. (2024). CBR-470-1 protects against cardiomyocyte death in ischaemia/reperfusion injury by activating the Nrf2-GPX4 cascade. Toxicology and Applied Pharmacology, 492, 117113. https://doi.org/10.1016/j.taap.2024.117113

Chicago

Qiu, Ze-Yang, Kai-Na Shi, Hui-Hua Li, and Bo Zhang. 2024. “CBR-470-1 Protects against Cardiomyocyte Death in Ischaemia/Reperfusion Injury by Activating the Nrf2-GPX4 Cascade.” Toxicology and Applied Pharmacology 492 (November): 117113. doi:10.1016/j.taap.2024.117113.